Welcure Drugs & Pharmaceuticals: Board Meeting Intimation for For Consideration And Approval Of The Audited Financial ResultsFor The Quarter/Year Ended 31St March 2025 Alongwith Statement Of Assets And Liabilities And Cash FlowStatement For The Year Ended 31St March 2025

Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve 1. To consider & approve the Audited financial results of the Company for the Quarter/Year ended31st March 2025.2. To take on record the Audit Report of the Statutory Auditors for the Audited Financial Resultsof the Company for the Quarter/Year ended 31st March 2025.3. To consider and approve the Audited Financial Statements including the Balance Sheet as at31st March 2025 and the Statement of Profits and Loss and Cash flow statement of change inequity and notes thereon for the year ended 31st March 2025.4. To Appoint Vishakha Agrawal & Associates Practicing Company Secretaries as the SecretarialAuditor of the Company for FY 2024-25.5. Any other business with permission of the Chairman.